Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 6;28(5):1236-1237.
doi: 10.1016/j.ymthe.2020.04.013. Epub 2020 Apr 17.

Check and Checkmate: Battling Cancer with Multiplex Immunotherapy

John C Bell  1
Affiliations
Comment

Check and Checkmate: Battling Cancer with Multiplex Immunotherapy

John C Bell. Mol Ther. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Chen D.S., Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321–330. - PubMed
    1. Porter C.E., Shaw A.R., Jung Y., Yip T., Castro P.D., Sandulache V.C., Sikora A., Gottschalk S., Ittman M.M., Brenner M.K., Suzuki M. Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors. Mol Ther. 2020;28:1251–1262. this issue. - PMC - PubMed
    1. Chen D.S., Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1–10. - PubMed
    1. Fu L.Q., Wang S.B., Cai M.H., Wang X.J., Chen J.Y., Tong X.M., Chen X.Y., Mou X.Z. Recent advances in oncolytic virus-based cancer therapy. Virus Res. 2019;270:197675. - PubMed
    1. Streby K.A., Currier M.A., Triplet M., Ott K., Dishman D.J., Vaughan M.R., Ranalli M.A., Setty B., Skeens M.A., Whiteside S. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019;27:1930–1938. - PMC - PubMed